Probiotics in the critically ill: A systematic review of the randomized trial evidence

Objective:Critical illness results in changes to the microbiology of the gastrointestinal tract, leading to a loss of commensal flora and an overgrowth of potentially pathogenic bacteria. Administering certain strains of live bacteria (probiotics) to critically ill patients may restore balance to the microbiota and have positive effects on immune function and gastrointestinal structure and function. The purpose of this systematic review was to evaluate the effect of probiotics in critically ill patients on clinical outcomes. Design:Systematic review. Interventions:None. Measurements and Main Results:We searched computerized databases, reference lists of pertinent articles, and personal files from 1980 to 2011. We included randomized controlled trials enrolling critically ill adults, which evaluated probiotics compared to a placebo and reported clinically important outcomes (infections, mortality, and length of stay). A total of 23 randomized controlled trials met inclusion criteria. Probiotics were associated with reduced infectious complications as documented in 11 trials (risk ratio 0.82; 95% confidence interval 0.69–0.99; p = .03; test for heterogeneity p = .05; I2 44%). When data from the seven trials reporting ventilator-associated pneumonia were pooled, ventilator-associated pneumonia rates were also significantly reduced with probiotics (risk ratio 0.75; 95% confidence interval 0.59–0.97; p = .03; test for heterogeneity p = .16; I2 35%). Probiotics were associated with a trend toward reduced intensive care unit mortality (risk ratio 0.80; 95% confidence interval 0.59–1.09; p = .16; test for heterogeneity p = .89; I2 0%) but did not influence hospital mortality. Probiotics had no effect on intensive care unit or hospital length of stay. Compared to trials of higher methodological quality, greater treatment effects were observed in trials of a lower methodological quality. Conclusions:Probiotics appear to reduce infectious complications including ventilator-associated pneumonia and may influence intensive care unit mortality. However, clinical and statistical heterogeneity and imprecise estimates preclude strong clinical recommendations. Further research on probiotics in the critically ill is warranted.

[1]  Shu-mei He,et al.  Bacteria‐free solution derived from lactobacillus plantarum inhibits multiple NF‐kappaB pathways and inhibits proteasome function , 2009, Inflammatory bowel diseases.

[2]  L. Morelli,et al.  Impact of antibiotics on the gut microbiota of critically ill patients. , 2008, Journal of medical microbiology.

[3]  J. Alverdy,et al.  Soluble factors from Lactobacillus GG activate MAPKs and induce cytoprotective heat shock proteins in intestinal epithelial cells. , 2006, American journal of physiology. Cell physiology.

[4]  B. Jeppsson,et al.  Lactobacillus plantarum 299v reduces colonisation of Clostridium difficile in critically ill patients treated with antibiotics , 2008, Acta anaesthesiologica Scandinavica.

[5]  J. Alverdy,et al.  Gut-Derived Sepsis Occurs When the Right Pathogen With the Right Virulence Genes Meets the Right Host: Evidence for In Vivo Virulence Expression in Pseudomonas aeruginosa , 2000, Annals of surgery.

[6]  M. Boermeester,et al.  Probiotic prophylaxis in predicted severe acute pancreatitis: a randomised, double-blind, placebo-controlled trial , 2008, The Lancet.

[7]  O. Cerović,et al.  Synbiotics, prebiotics, glutamine, or peptide in early enteral nutrition: a randomized study in trauma patients. , 2007, JPEN. Journal of parenteral and enteral nutrition.

[8]  C. Mcnaught,et al.  A prospective randomised study of the probiotic Lactobacillus plantarum 299V on indices of gut barrier function in elective surgical patients , 2002, Gut.

[9]  J. Alverdy,et al.  The re‐emerging role of the intestinal microflora in critical illness and inflammation: why the gut hypothesis of sepsis syndrome will not go away , 2008, Journal of leukocyte biology.

[10]  A. Nashimoto,et al.  Probiotics reduce infectious complications after pancreaticoduodenectomy. , 2007, Hepato-gastroenterology.

[11]  Thomas R. Riley,et al.  A Randomized Double-blind Placebo-controlled Trial , 2004 .

[12]  T. Fabian,et al.  Lactobacillus Species as a Cause of Ventilator‐Associated Pneumonia in a Critically Ill Trauma Patient , 2002, Pharmacotherapy.

[13]  N. Mendes,et al.  Infection prevention in patients with severe multiple trauma with the immunomodulator beta 1-3 polyglucose (glucan). , 1993, Surgery, gynecology & obstetrics.

[14]  Gerta Rücker,et al.  Arcsine test for publication bias in meta‐analyses with binary outcomes , 2008, Statistics in medicine.

[15]  C. Bulpitt,et al.  Use of probiotic Lactobacillus preparation to prevent diarrhoea associated with antibiotics: randomised double blind placebo controlled trial , 2007, BMJ : British Medical Journal.

[16]  M. Hollingsworth,et al.  Probiotics inhibit enteropathogenic E. coliadherence in vitro by inducing intestinal mucin gene expression. , 1999, American journal of physiology. Gastrointestinal and liver physiology.

[17]  C. Mcnaught,et al.  Influence of synbiotic containing Lactobacillus acidophilus La5, Bifidobacterium lactis Bb 12, Streptococcus thermophilus, Lactobacillus bulgaricus and oligofructose on gut barrier function and sepsis in critically ill patients: a randomised controlled trial. , 2004, Clinical nutrition.

[18]  H. Sahl,et al.  Lipid II-Based Antimicrobial Activity of the Lantibiotic Plantaricin C , 2006, Applied and Environmental Microbiology.

[19]  B. Birkenfeld,et al.  A controlled, double-blind, randomized study on the efficacy of Lactobacillus plantarum 299V in patients with irritable bowel syndrome , 2001, European journal of gastroenterology & hepatology.

[20]  D. Seehofer,et al.  Early enteral supply of lactobacillus and fiber versus selective bowel decontamination: a controlled trial in liver transplant recipients , 2002, Transplantation.

[21]  A. Steiber,et al.  A Randomized, Double-blind, Placebo-controlled Pilot Study of Lactobacillus reuteri ATCC 55730 for the Prevention of Antibiotic-associated Diarrhea in Hospitalized Adults , 2011, Journal of clinical gastroenterology.

[22]  Kevin Whelan,et al.  Safety of probiotics in patients receiving nutritional support: a systematic review of case reports, randomized controlled trials, and nonrandomized trials. , 2010, The American journal of clinical nutrition.

[23]  Stefano Guandalini,et al.  Recommendations for probiotic use-2011 update. , 2011, Journal of clinical gastroenterology.

[24]  Patricia Muñoz,et al.  Saccharomyces cerevisiae fungemia: an emerging infectious disease. , 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[25]  J. D. Young,et al.  The use of pre- pro- and synbiotics in adult intensive care unit patients: systematic review. , 2007, Clinical nutrition.

[26]  A. Pfeifer,et al.  Probiotics and immune response , 2002, Clinical reviews in allergy & immunology.

[27]  S. Bengmark,et al.  Effect of synbiotic therapy on the incidence of ventilator associated pneumonia in critically ill patients: a randomised, double-blind, placebo-controlled trial , 2009, Intensive Care Medicine.

[28]  A. Oláh,et al.  Randomized clinical trial of specific lactobacillus and fibre supplement to early enteral nutrition in patients with acute pancreatitis , 2002, The British journal of surgery.

[29]  Leah Gramlich,et al.  Canadian clinical practice guidelines for nutrition support in mechanically ventilated, critically ill adult patients. , 2003, JPEN. Journal of parenteral and enteral nutrition.

[30]  Min Tan,et al.  Effects of probiotics on serum levels of Th1/Th2 cytokine and clinical outcomes in severe traumatic brain-injured patients: a prospective randomized pilot study , 2011, Critical care.

[31]  A. Larsson,et al.  Adhesion of the probiotic bacterium Lactobacillus plantarum 299v onto the gut mucosa in critically ill patients: a randomised open trial , 2005, Critical care.

[32]  M. Gatt,et al.  Randomized clinical trial of gut‐specific nutrients in critically ill surgical patients , 2010, The British journal of surgery.

[33]  F. Maurier,et al.  [Prevention of diarrhea administering Saccharomyces boulardii during continuous enteral feeding]. , 1983, La semaine des hopitaux : organe fonde par l'Association d'enseignement medical des hopitaux de Paris.

[34]  C. Mcnaught,et al.  A prospective randomised trial of probiotics in critically ill patients. , 2005, Clinical nutrition.

[35]  M. Washington,et al.  Soluble proteins produced by probiotic bacteria regulate intestinal epithelial cell survival and growth. , 2007, Gastroenterology.

[36]  E. Söderling,et al.  Probiotic Lactobacilli Interfere with Streptococcus mutans Biofilm Formation In Vitro , 2011, Current Microbiology.

[37]  C. Bulpitt,et al.  Probiotics in prevention of antibiotic associated diarrhoea: meta-analysis , 2002, BMJ : British Medical Journal.

[38]  J. Lachaine,et al.  Effect of a fermented milk combining Lactobacillus acidophilus Cl1285 and Lactobacillus casei in the prevention of antibiotic-associated diarrhea: a randomized, double-blind, placebo-controlled trial. , 2007, Canadian journal of gastroenterology = Journal canadien de gastroenterologie.

[39]  C. De Simone,et al.  DNA from probiotic bacteria modulates murine and human epithelial and immune function. , 2004, Gastroenterology.

[40]  D. Seehofer,et al.  Effect of Enteral Nutrition and Synbiotics on Bacterial Infection Rates After Pylorus-preserving Pancreatoduodenectomy: A Randomized, Double-blind Trial , 2007, Annals of surgery.

[41]  K. Kotzampassi,et al.  Benefits of a Synbiotic Formula (Synbiotic 2000Forte®) in Critically Ill Trauma Patients: Early Results of a Randomized Controlled Trial , 2006, World Journal of Surgery.

[42]  F. Alla,et al.  Probiotics in the critically ill patient: a double blind, randomized, placebo-controlled trial , 2010, Intensive Care Medicine.

[43]  J. Versalovic,et al.  Human-derived probiotic Lactobacillus reuteri demonstrate antimicrobial activities targeting diverse enteric bacterial pathogens. , 2008, Anaerobe.

[44]  N. Laird,et al.  Meta-analysis in clinical trials. , 1986, Controlled clinical trials.

[45]  D. Chung,et al.  Lipoteichoic Acid Isolated from Lactobacillus plantarum Inhibits Lipopolysaccharide-Induced TNF-α Production in THP-1 Cells and Endotoxin Shock in Mice1 , 2008, The Journal of Immunology.

[46]  H. Bléhaut,et al.  Saccharomyces boulardii prevents diarrhea in critically ill tube-fed patients , 1997, Intensive Care Medicine.

[47]  J. Bailey,et al.  Probiotics for Disease Prevention: A Focus on Ventilator-Associated Pneumonia , 2011, The Annals of pharmacotherapy.

[48]  J. Huizinga,et al.  Lactobacillus reuteri ingestion prevents hyperexcitability of colonic DRG neurons induced by noxious stimuli. , 2009, American journal of physiology. Gastrointestinal and liver physiology.

[49]  J. Brophy,et al.  Probiotic therapy for the prevention and treatment of Clostridium difficile-associated diarrhea: a systematic review , 2005, Canadian Medical Association Journal.

[50]  Gregor Reid,et al.  Potential Uses of Probiotics in Clinical Practice , 2003, Clinical Microbiology Reviews.

[51]  H. Qin,et al.  Effect of Lactobacillus plantarum enteral feeding on the gut permeability and septic complications in the patients with acute pancreatitis , 2008, European Journal of Clinical Nutrition.

[52]  Kazuhisa Yoshiya,et al.  Altered gut flora and environment in patients with severe SIRS. , 2006, The Journal of trauma.

[53]  T. Casale,et al.  Probiotic prophylaxis of ventilator-associated pneumonia: a blinded, randomized, controlled trial. , 2010, American journal of respiratory and critical care medicine.

[54]  M. Sanders,et al.  New scientific paradigms for probiotics and prebiotics. , 2003, Journal of clinical gastroenterology.

[55]  D. Heyland,et al.  Should immunonutrition become routine in critically ill patients? A systematic review of the evidence. , 2001, JAMA.

[56]  C. Mcnaught,et al.  An investigation into the effect of a probiotic on gut immune function in surgical patients. , 2004, Clinical nutrition.

[57]  M. Nagino,et al.  Synbiotics reduce postoperative infectious complications: a randomized controlled trial in biliary cancer patients undergoing hepatectomy , 2005, Langenbeck's Archives of Surgery.

[58]  D. Seehofer,et al.  Early enteral supply of fiber and Lactobacilli versus conventional nutrition: a controlled trial in patients with major abdominal surgery. , 2002, Nutrition.

[59]  O. Tasaki,et al.  Synbiotics Decrease the Incidence of Septic Complications in Patients with Severe SIRS: A Preliminary Report , 2009, Digestive Diseases and Sciences.

[60]  D. Seehofer,et al.  Supply of Pre‐ and Probiotics Reduces Bacterial Infection Rates After Liver Transplantation—A Randomized, Double‐Blind Trial , 2005, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[61]  A. Moir,et al.  Mode of action, purification and amino acid sequence of plantaricin C19, an anti-Listeria bacteriocin produced by Lactobacillus plantarum C19. , 2001, International journal of food microbiology.

[62]  J. Mary,et al.  Ineffectiveness of Lactobacillus johnsonii LA1 for prophylaxis of postoperative recurrence in Crohn’s disease: a randomised, double blind, placebo controlled GETAID trial , 2005, Gut.

[63]  M. Gatt,et al.  Randomized clinical trial of effect of synbiotics, neomycin and mechanical bowel preparation on intestinal barrier function in patients undergoing colectomy , 2007, The British journal of surgery.

[64]  M. Falagas,et al.  Impact of the administration of probiotics on the incidence of ventilator-associated pneumonia: A meta-analysis of randomized controlled trials* , 2010, Critical care medicine.

[65]  M. Nagino,et al.  Perioperative Synbiotic Treatment to Prevent Postoperative Infectious Complications in Biliary Cancer Surgery: A Randomized Controlled Trial , 2006, Annals of surgery.

[66]  L. Mccargar,et al.  Effects of probiotic therapy in critically ill patients: a randomized, double-blind, placebo-controlled trial. , 2007, The American journal of clinical nutrition.

[67]  V. Raia,et al.  Effect of Lactobacillus GG supplementation on pulmonary exacerbations in patients with cystic fibrosis: a pilot study. , 2007, Clinical nutrition.

[68]  C. Prantera,et al.  Ineffectiveness of probiotics in preventing recurrence after curative resection for Crohn's disease: a randomised controlled trial with Lactobacillus GG , 2002, Gut.

[69]  M. Kleerebezem,et al.  Regulation of human epithelial tight junction proteins by Lactobacillus plantarum in vivo and protective effects on the epithelial barrier. , 2010, American journal of physiology. Gastrointestinal and liver physiology.

[70]  A. Oláh,et al.  [Combination of early nasojejunal feeding with modern synbiotic therapy in the treatment of severe acute pancreatitis (prospective, randomized, double-blind study)]. , 2005, Magyar sebeszet.

[71]  D. Seehofer,et al.  Prebiotics, probiotics, synbiotics in surgery—are they only trendy, truly effective or even dangerous? , 2009, Langenbeck's Archives of Surgery.

[72]  P. Neuhaus,et al.  Einfluss von Probiotika und Ballaststoffen auf die Inzidenz bakterieller Infektionen nach viszeralchirurgischen Eingriffen - Ergebnisse einer prospektiven Studie , 2002 .

[73]  C. Hill,et al.  Bacteriocin production as a mechanism for the antiinfective activity of Lactobacillus salivarius UCC118 , 2007, Proceedings of the National Academy of Sciences.

[74]  T. Venkatesan.  Probiotic Prophylaxis in Predicted Severe Acute Pancreatitis: A Randomised, Double-Blind, Placebo-Controlled Trial. , 2008, Nutrition in clinical practice : official publication of the American Society for Parenteral and Enteral Nutrition.

[75]  L. Mcfarland.  Meta-Analysis of Probiotics for the Prevention of Antibiotic Associated Diarrhea and the Treatment of Clostridium difficile Disease , 2006, The American Journal of Gastroenterology.

[76]  Z. Haddad,et al.  Antibiotics for preventing infections in open fractures are protective against ventilator-associated pneumonia , 2005, Neurology.

[77]  T. Gillart,et al.  Oral probiotic and prevention of Pseudomonas aeruginosa infections: a randomized, double-blind, placebo-controlled pilot study in intensive care unit patients , 2008, Critical care.

[78]  C. Surawicz,et al.  The search for a better treatment for recurrent Clostridium difficile disease: use of high-dose vancomycin combined with Saccharomyces boulardii. , 2000, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[79]  C. Mcnaught,et al.  Randomised clinical trial of synbiotic therapy in elective surgical patients , 2004, Gut.

[80]  Chunmao Han,et al.  [Preliminary comparative study on the effects of early enteral supplementation of synbiotics on severely burned patients]. , 2004, Zhonghua shao shang za zhi = Zhonghua shaoshang zazhi = Chinese journal of burns.

[81]  W. Chaboyer,et al.  Decrease in frequency of liquid stool in enterally fed critically ill patients given the multispecies probiotic VSL#3: a pilot trial. , 2010, American journal of critical care : an official publication, American Association of Critical-Care Nurses.

[82]  A. Saraya,et al.  Role of Probiotics on Gut Permeability and Endotoxemia in Patients With Acute Pancreatitis: A Double-Blind Randomized Controlled Trial , 2011, Journal of clinical gastroenterology.

[83]  M. Roberfroid,et al.  Dietary modulation of the human colonic microbiota: updating the concept of prebiotics , 2004, Nutrition Research Reviews.

[84]  L. Miller,et al.  Dose–Response Efficacy of a Proprietary Probiotic Formula of Lactobacillus acidophilus CL1285 and Lactobacillus casei LBC80R for Antibiotic-Associated Diarrhea and Clostridium difficile-Associated Diarrhea Prophylaxis in Adult Patients , 2010, The American Journal of Gastroenterology.

[85]  G R Gibson,et al.  Dietary modulation of the human colonic microbiota: introducing the concept of prebiotics. , 1995, The Journal of nutrition.

[86]  E. Giamarellos‐Bourboulis,et al.  Pro- and synbiotics to control inflammation and infection in patients with multiple injuries. , 2009, The Journal of trauma.

[87]  Pengfei Guo,et al.  A meta-analysis of randomized controlled trials , 2019, Medicine.

[88]  Ping Yang,et al.  Use of pre-, pro- and synbiotics in patients with acute pancreatitis: a meta-analysis. , 2010, World journal of gastroenterology.

[89]  S. Ferrie,et al.  Lactobacillus GG as treatment for diarrhea during enteral feeding in critical illness: randomized controlled trial. , 2011, JPEN. Journal of parenteral and enteral nutrition.

[90]  F. Bäckhed,et al.  Host-Bacterial Mutualism in the Human Intestine , 2005, Science.

[91]  J. E. de Aguilar-Nascimento,et al.  Benefits of early enteral nutrition with glutamine and probiotics in brain injury patients. , 2004, Clinical science.

[92]  M. Cassone,et al.  Outbreak of Saccharomyces cerevisiae Subtype boulardii Fungemia in Patients Neighboring Those Treated with a Probiotic Preparation of the Organism , 2003, Journal of Clinical Microbiology.

[93]  D. Heimburger,et al.  Diarrhea with enteral feeding: prospective reappraisal of putative causes. , 1994, Nutrition.

[94]  Kehu Yang,et al.  Probiotics in patients with severe acute pancreatitis: a meta-analysis , 2008, Langenbeck's Archives of Surgery.

[95]  W. Hammes,et al.  Safety of probiotics that contain lactobacilli or bifidobacteria. , 2003, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[96]  M. Schlotterer,et al.  Intérêt de Saccharomyces boulardii dans la tolérance digestive de la nutrition entérale à débit continu chez le brûlé , 1987 .